Zobrazeno 1 - 10
of 39
pro vyhledávání: '"M Arn"'
Autor:
M. Arn, H.-R. Koelz
Zusammenfassung: Die allgemeinen medizinischen, noch mehr aber die gastroenterologischen Fortschritte der letzten 25Jahre würden erwarten lassen, dass gastrointestinale Blutungen seltener und deren Letalität heute geringer sind. Die publizierten ep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43580afc1c9ce6c855b3bd51d5746de2
http://doc.rero.ch/record/320950/files/104_2005_Article_1142.pdf
http://doc.rero.ch/record/320950/files/104_2005_Article_1142.pdf
Autor:
Waldo Valenzuela, Fabian Balsiger, Benedikt Wagner, C. Steindel, Mauricio Reyes, Olivier Scheidegger, M. Arn, Marwan El-Koussy, Kai M. Rösler
Publikováno v:
Clinical Neurophysiology. 129:e70-e71
Background Current state-of-the-art to diagnose peripheral neuropathy are neurological examination and electrodiagnostic studies. However, deeply situated nerves and plexus remain difficult to assess using these techniques, hence magnetic resonance n
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thenard, M. Arn.
Publikováno v:
Scientific American, 1877 Jun . 36(25), 391-391.
Externí odkaz:
https://www.jstor.org/stable/26067471
Publikováno v:
Digestive Diseases and Sciences. 46:2499-2503
Somatostatin inhibits colonic ion secretion in animal models and cultured intestinal cell lines via somatostatin receptor subtype 2 and subtype 1, respectively. In a recent in vitro ion transport study of the human colon, somatostatin was shown to st
Publikováno v:
Digestive Diseases and Sciences. 45:2100-2107
In vitro somatostatin is a potent inhibitor of intestinal ion secretion in animal models and cultured human cell lines, providing a rationale for its use in secretory diarrheas. However, the effects of somatostatin on ion transport in native human co
Autor:
Eberhard L. Renner, D. Criblez, Beat Meyer-Wyss, Hp Egger, Jean-Jacques Gonvers, L. Rossi, M. Arn, Christa Meyenberger, Beat Müllhaupt, P. Rich, C. Rammert, Beat Helbling, Carl Oneta, Jan Borovicka
Publikováno v:
Journal of viral hepatitis. 13(7)
Health regulatory approval of the 1.5 microg/kg body weight dose of pegylated interferon (PEG-I) alpha-2b in combination with ribavirin for the treatment of chronic hepatitis C was based on a study using PEG-I alpha-2b at doses of only 0.5 and 1.5 mi
Autor:
H-R, Koelz, M, Arn
Publikováno v:
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 77(2)
Due to progress in general medicine and especially in gastroenterology, the incidence of acute gastrointestinal hemorrhage could be expected to have decreased during the last 25 years. However, published epidemiological data cannot, in general, fulfi
Publikováno v:
Digestive diseases and sciences. 46(11)
Somatostatin inhibits colonic ion secretion in animal models and cultured intestinal cell lines via somatostatin receptor subtype 2 and subtype 1, respectively. In a recent in vitro ion transport study of the human colon, somatostatin was shown to st
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum.